Nephrology and Urology Devices Market USD 22.5 Billion by 2020, Published by iHealthcareAnalyst, Inc.

Maryland Heights, MO, October 06, 2016 --(PR.com)-- The global nephrology and urology devices market is estimated to reach USD 22.5 Billion in 2020, growing at a CAGR of 5.9% from 2016 to 2020, according to a market research report Nephrology and Urology Devices Market 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Nephrology and Urology Devices Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/next-generation-sequencing-market/
The global nephrology and urology devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global nephrology and urology devices market segmentation is based on device types (dialysis devices, urinary stone treatment, lithotripters, ureteral stents, incontinence and pelvic organ prolapse treatment, sacral neuromodulation, mesh and slings, urinary incontinence and pelvic organ prolapse treatment devices, benign prostatic hyperplasia devices, BPH catheterization ablation devices, prostatic stents, endoscopy devices). The global nephrology and urology devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global nephrology and urology devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Device Type
1.1. Benign Prostatic Hyperplasia Devices
1.1.1.BPH Catheterization Ablation Devices
1.1.2. Prostatic Stents
1.1.3. Others
1.2. Dialysis Devices
1.3. Endoscopy Devices
1.4. Incontinence & Pelvic Organ Prolapse Treatment
1.4.1. Sacral Neuromodulation
1.4.2. Mesh and Slings
1.4.3. Urethral Inserts and Pessaries
1.5. Urinary Stone Treatment
1.5.1. Lithotripters
1.5.2. Stone Retrieval Baskets
1.5.3. Ureteral Stents

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Asahi Kasei Corp.
3.2. B. Braun Group
3.3. Baxter International Inc.
3.4. C. R. Bard Inc.
3.5. Cook Group Incorporated
3.6. Dornier Medtech
3.7. Fresenius Medical Care
3.8. Nikkiso Co. Ltd.
3.9. Nipro Corporation
3.10. Nxstage Medical Inc
3.11. Rockwell Medical Technologies, Inc.
3.12. Terumo Corporation

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
ContactContact
Categories